The future of the global wearable medical device market looks promising with opportunities in the healthcare & medical and remote patient monitoring markets.
- Within the distribution channel category, online is expected to witness higher growth over the forecast period due to the increasing preference for convenient online medical device purchases.
- Within the end use category, healthcare & medical is expected to witness higher growth over the forecast period due to the rising adoption of continuous patient health monitoring.
- In terms of regions, APAC is expected to witness the highest growth over the forecast period due to the expanding healthcare infrastructure and digital health adoption.
Emerging Trends in Wearable Medical Device Market
The wearable medical device market will shift from standalone trackers to clinically validated connected devices by 2025 to 2027. Lucintel projects the growth will be in the areas of chronic condition management and remote patient monitoring with the trend of sensor miniaturization. There are not many hurdles to the adoption of the technology, with hospital integration and reimbursement along with consumer demand for preventive care pushing the trend along. Data security and the level of clinical evidence remain hurdles, but not stop gaps.- Clinical-grade Sensing: Wearables are adding more parameters to their measurements to include continuous glucose readings, ECGs, oxygen saturation and blood pressure estimations, to name a few. The FDA is reviewing and approving more than 500 AI-enabled medical devices to be used in the diagnosis of a medical condition, further increasing expectations of validated algorithms. Better accuracy will help hospitals replace episodic testing with continuous observation.
- Digital Integration: More integration is occurring between wearables, smartphones and EHRs. The focus for the next several years will be on transforming data into actionable information. If new devices provide yet another dashboard for clinicians, they may not be purchased, but if devices integrate with existing systems and provide clinically relevant data, they will be purchased quickly.
- Miniaturization and Comfort: The size and weight of medical devices will continue to decrease. More comfortable devices will improve adherence, especially for elderly patients that are required to continuously monitor their conditions. This is also applicable to patients with diabetes, cardiovascular conditions, and respiratory conditions. The devices will also be easier to charge and batteries will last longer.
- Regulatory and Cybersecurity Maturity: The FDA’s 2025 deadline for all medical devices to meet specific cybersecurity guidelines will help provide a secure and protected framework to transfer clinically relevant data. Manufacturers will rise to the top with secured data flows and documented clinical evidence.
Recent Developments in the Wearable Medical Device Market
Medical device activity in the wearable medical device space is accelerating through 2025-2027 as remote monitoring moves into reimbursed care pathways. Lucintel’s perspective is aligned with the shift toward clinically validated sensors, software-enabled services, and home-based diagnostics. Capital markets will back companies that demonstrate outcomes, build relationships with hospitals, and manage regulatory risk.- Reimbursement Expansion: CMS retained the remote physiologic monitoring payment codes in January 2025. The retention of these codes strengthened recurring revenue models. Better payment visibility will allow providers to expand wearable medical device programs beyond pilot programs.
- Clinical-grade Glucose Monitoring: Dexcom announced expanded Stelo availability outside the US in February 2025, priced to compete with lower-end CGMs. Greater affordability will drive broader adoption and force competitors to simplify reimbursement and pricing.
- Strategic Data Partnerships: Oura and Dexcom unveiled an integration to connect glucose data and biometric data in February 2025. Using continuous, real-time data will allow companies to create personalized, real-time coaching and improve user engagement and retention.
- Regulatory Approval of AI Wearables: The FDA issued more than 1,000 authorizations of AI-enabled medical devices by August 2025. This will accelerate development of various medical devices. Companies must change their focus from wellness to clinical.
- Manufacturing Scale-up: Abbott announced a $2.5B investment to build new medical device manufacturing facilities in the US in March 2025. Greater capacity and scale will ultimately reduce costs for medical devices.
Strategic Growth Opportunities in the Wearable Medical Device Market
The wearable medical device market is approaching a wider commercial phase due to the convergence of remote care reimbursement, consumer interest, and the need for chronic-care disease monitoring. From 2024 to 2026, the cost of sensors decreased while hospitals focused on earlier intervention and adherence data. Lucintel expects the opportunity would be in the shift from device sales to recurring software, services and clinically validated data.- Chronic Care Monitoring: In January 2025, the FDA published a framework outlining its approach for reviewing Artificial Intelligence (AI) / Machine Learning (ML) based medical devices, which opened the pathway for the use of wearables in a broader spectrum of medical devices. Within the next three to five years, Lucintel expects the focus will be on subscription-based monitoring services for chronic conditions such as diabetes, cardiac, and hypertension.
- Employer Health Programs: In 2025, the U.S. accounted for approximately 60% of global corporate wellness spending. We expect this to drive investment in remote monitoring of health and wellness, as well as prevention and absence programs. Insurance companies and employers will purchase outcome-based programs rather than standalone equipment.
- Premium Clinical Wearables: Apple disclosed it had over 2.5 billion active devices on its ecosystem in February 2025. This creates a greater need for higher-value sensors. Companies that fuse medical and consumer design in their products can gain better market positions. This would be evident in cardiac assessments and rehabilitation, for example.
- Emerging Market Expansion: In April 2025, the Indian government announced it had verified over 1.5 billion Aadhaar digital identities. The use of remote health and wellness solutions enabled by India’s digital infrastructure is strong and growing. This, along with other regions, is a prime market for lower cost, remote monitoring, and diagnostic wearable devices.
- Aftermarket Data Services: The volume of connected devices shipped globally in 2025 was approximately 1.7 billion. This creates an even larger opportunity for aftermarket data and technical services. We expect companies will focus more on selling and leveraging data rather than only selling hardware. There will be a greater focus on the follow-on services, post-sale, that are reimbursable, rather than just the hardware.
Wearable Medical Device Market Drivers and Challenges
Development in the fields of medical technology, expanding demand for healthcare services, and changes in regulatory framework create a favorable environment for development of the wearable medical device industry. Continuous innovation in sensors, connectivity, and artificial intelligence combined with remote patient monitoring is improving the clinical value of medical devices. However, making such devices affordable, while addressing privacy concerns, and addressing the challenges of manufacturing at scale, will impact future opportunities and market adoption of such devices. The report from Lucintel, “Growth Opportunities in the Wearable Medical Devices Market 2020-2025”, identifies some of the key drivers for this market, and also provides insights into challenges and future prospects.The factors responsible for driving this market include:
- Increasing Prevalence of Chronic Diseases: The older population (people 60 years and above) was approximately 1.1 billion in 2025, creating the need for home-based monitoring. Furthermore, in the next 3-5 years, chronic conditions will create an increased need for healthcare systems to use wearables for earlier intervention, reduced hospital visits, and personalized treatment management.
- Rapid Advances in Technology: Advances in biosensors, microelectronics, and other components allow devices to become smaller, more accurate, and more clinically useful. Wearables can now continuously monitor multiple parameters, identify patterns and send data to a remote location via the Internet. In 2026, the United States Food and Drug Administration Quality Management System Regulations became effective requiring manufacturers to enhance their quality and manufacturing systems for medical devices. This, along with improved reliability of sensors and other components, will create increased clinical acceptance for wearable devices in the 3-5-year period, allowing its usage for diagnosis and treatment, beyond just fitness and wellness.
- Artificial Intelligence and Data Analytics: Artificial Intelligence (AI) is getting better at analyzing continuous streams of physiological data to identify deviations and issues. This is also playing a part in development of predictive health risk models. In addition, AI is being used to personalize notifications within wearables. Along these lines, AI is being integrated with clinicians’ EHRs and telehealth platforms, to more easily transform raw and streamed data to actionable information. In 2025, several Digital Health companies were continuing to expand their predictive/preventative analytics into areas such as neurological conditions, mental health, and various metabolic conditions. It’s likely that similarly validated analytics will continue to improve the diagnostic value of these devices, positioning them to aid in the clinician’s ability to appropriately manage and integrate these devices into regular workflows.
- Remote Patient Monitoring and Telehealth: The use of remote patient monitoring (outside of traditional hospital settings) to manage certain conditions is growing among hospitals and payors. The use of continuous and/or frequent monitoring can play a role in limiting unnecessary and avoidable visits to/stays in the hospital. Wearable devices can play a role in transforming the traditional and time-consuming in-person observation of a patient following a discharge to a more continuous and remote observation. The development and rapid growth of remote-care programs focused on cardiovascular conditions, diabetes and related metabolic conditions, respiratory conditions, neurological conditions, and rehabilitative care, where real time and frequent monitoring can help improve the timing of interventions and care, will continue in the next three to five years. It is expected that ongoing growth and investment in virtual-care infrastructure and reimbursement models tied to clinical outcomes will continue to enhance demand for connected devices designed to support care management.
The challenges facing this market include:
- Threats from Loss of Confidentiality: Continuous, real-time, and location-based data collected by wearable devices may create unauthorized access, authentication, data sharing, and ransomware vulnerabilities. Cybersecurity incidents reported by the healthcare sector demonstrate the risks posed to patient data. In the next three to five years, due to the heightened pace of connectivity, the demands of consumer expectations for data protection, and the anticipation of more stringent regulations, organizations will be challenged to embrace protections such as end-to-end encryption, secure software and firmware updates, and strengthened governance. Inadequate data protection would most likely result in regulatory penalties, damaged reputation and lost business.
- Regulatory and Clinical Validation Barriers: A broader range of considerations, including safety, accuracy and performance of software and clinical evidence, as well as post-market surveillance, add to the complexity of regulatory requirements for medical wearables. Artificial Intelligence updates for medical devices can increase the level of uncertainty in regulatory approvals. Starting from February 2026, the Quality Management System Regulation in the United States puts more emphasis on documented quality systems and control of manufacturing processes. In the near- to mid-term, increased regulatory requirements will likely drive up the cost of development, lengthen the time to bring medical devices to market and limit the number of products available, although in the end reliable and functional medical devices will be differentiated from non-medical products.
- High Costs and Reimbursement Uncertainty: Wearables for medical use incorporate advanced technologies, and often require investments in clinical studies, secure cloud infrastructure, and regulatory affairs. These increase costs and stretches lead times. Hospitals tend to be risk-averse towards wearables when reimbursement policies do not account for remote monitoring and when the benefits of wearables are not clearly established. Healthcare payors also favored technologies with measurable outcomes and quick returns on investment in 2025. These circumstances increased the scrutiny of procurement. Unequal digital access and pressures on budget may slow the adoption of medical wearables in the near- to mid-term, especially in lower- and middle-income countries, unless manufacturers demonstrate clear and durable clinical value.
List of Wearable Medical Device Market Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies wearable medical device market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base.Some of the wearable medical device market companies profiled in this report include:
- Johnson & Johnson
- Smiths Medical Inc - Smiths Group Plc
- Koninklijke Philips N.V.
- Roche Holding AG
- Medtronic plc
Wearable Medical Device Market by Segment
The study includes a forecast for the global wearable medical device market by distribution channel, application, end use, and region.Distribution Channel [Value ($M) from 2019 to 2035]:
- Pharmacies & Clinics
- Online
- Others
Application [Value ($M) from 2019 to 2035]:
- Diagnostics
- Therapeutics
End Use [Value ($M) from 2019 to 2035]:
- Healthcare & Medical
- Remote Patient Monitoring
Region [Value ($M) from 2019 to 2035]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
Country Wise Outlook for the Wearable Medical Device Market
Regulatory expansion, localized manufacturing, and connected-care partnerships are shaping the medical device market. Manufacturers are focusing on continuous glucose, cardiac, and neurological monitoring, as well as other remote-monitoring devices from 2025 to 2027. According to Lucintel's most recent market research, these advancements are improving the commercialization of various medical devices across key markets of the healthcare industry.- United States: As of August 2024, Dexcom’s Stelo, an over-the-counter glucose biosensor, will receive its first FDA clearance to be sold without prescription to adults not using insulin. Stelo will be used for self-monitoring blood glucose levels and will show results every 15 minutes. As a part of FDA’s regulatory pathway for over the counter glucose biosensors, Stelo has helped create an important precedent. Other companies have also followed the FDA regulatory pathway to gain authorization to sell they’re over the counter glucose biosensors. In the next 3-5 years, it is expected that the FDA will continue to grant authorization for customer-accessible monitoring products and, as a result, expand the distribution of glucose biosensors through retail pharmacies and digital health.
- China: In 2025, Chinese manufacturers will continue to seek approval from the National Medical Products Administration (NMPA) while Huawei and its hospital partners, will continue to advance their Trusense-based monitoring technology that covers more than 60 health indicators. With the existing hardware and digital health infrastructure in China continuing to expand, combined with local hospital validations and partnerships with Huawei, a formidable offering in digital health will soon be on the market.
- Germany: Siemens Healthineers committed approximately €1.1 billion for 2025 for research and development on digital and monitoring technologies. German MedTech companies continue to integrate sensor modules in their hospital and home-care devices. This investment is expected to support development of higher-value wearables, strengthen Germany’s MedTech ecosystem and manufacturing presence in the EU.
- India: The Indian government is committed to the production-linked incentive scheme for medical devices (PLI-MD) worth ₹3,420 crore (approximately $424 million) until 2025. Local companies are also partnering with hospitals and technology companies to develop connected health solutions. The PLI-MD will support localization of higher-value manufacturing, lead to increased assembly of connected care devices and reduce reliance on imported components over the next three to five years.
- Japan: The Japanese government continued to support the use of digital and monitoring technologies in health in 2025. Companies like Terumo and Omron continued to expand their collaboration to offer connected care services. Omron also launched a digital health product for home use, which has the capacity to store 100 blood pressure readings in 2025. The continued emphasis and integration of digital and remote care in the national health strategies will drive the adoption of wearable devices for home-based health monitoring.
Features of the Global Wearable Medical Device Market
- Market Size Estimates: wearable medical device market size estimation in terms of value ($M).
- Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
- Segmentation Analysis: wearable medical device market size by distribution channel, application, end use, and region in terms of value ($M).
- Regional Analysis: wearable medical device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different distribution channel, application, end use, and regions for the wearable medical device market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the wearable medical device market.- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the wearable medical device market by distribution channel (pharmacies & clinics, online, and others), application (diagnostics and therapeutics), end use (healthcare & medical and remote patient monitoring), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Johnson & Johnson
- Smiths Medical Inc – Smiths Group Plc
- Koninklijke Philips N.V.
- Roche Holding AG
- Medtronic plc
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.

LOADING...

